Pediatric Cavernous Malformation Treatment

see also Cavernous Malformation Treatment.

The management needs to include consideration of the lifetime risk of hemorrhage, as well as the possibility of development of epilepsy. If in an accessible location, most cavernomas should be surgically removed in a timely fashion to provide lifelong cure for pediatric patients 1).

Surgery is a safe and efficient treatment option with excellent outcomes in patients 2).

Early intervention is recommended to resect CMs, the hemosiderin rim, and the epileptogenic cortex, even in cases of multiple CMs 3).

Complete resection must be attempted to reduce the risk of postoperative rebleeding 4).

Even in cases of multiple cerebral cavernous malformations and epilepsy, surgery should be considered 5). The treatment modalities must be considered cautiously. A much longer follow-up remains mandatory for appropriate treatment strategies 6).

Directions for future evaluation include minimally invasive procedures, as well as potential for an increased role of medical management using targeted molecular therapies 7).

With the assistance of neuronavigation systems, intraoperative neuromonitoring, and TTRS, CMs could be targeted more accurately and excised more safely. Based on the satisfactory seizure outcome achieved, complete microsurgical excision in children is recommended for CMs presenting with seizures but removal of hemosiderin-stained areas seems to be unnecessary 8).


1)
Kosnik-Infinger L, Carroll C, Greiner H, Leach J, Mangano FT. Management of cerebral cavernous malformations in the pediatric population: a literature review and case illustrations. J Neurosurg Sci. 2015 Sep;59(3):283-94. Epub 2015 May 22. Review. PubMed PMID: 25998208.
2)
Knerlich-Lukoschus F, Steinbok P, Dunham C, Cochrane DD. Cerebellar cavernous malformation in pediatric patients: defining clinical, neuroimaging, and therapeutic characteristics. J Neurosurg Pediatr. 2015 Sep;16(3):256-66. doi: 10.3171/2015.1.PEDS14366. Epub 2015 May 22. PubMed PMID: 26053436.
3)
Lin Q, Yang PF, Jia YZ, Pei JS, Xiao H, Zhang TT, Zhong ZH, Wang SS. Surgical Treatment and Long-Term Outcome of Cerebral Cavernous Malformations-Related Epilepsy in Pediatric Patients. Neuropediatrics. 2018 Apr 20. doi: 10.1055/s-0038-1645871. [Epub ahead of print] PubMed PMID: 29677701.
4)
Li D, Hao SY, Tang J, Xiao XR, Jia GJ, Wu Z, Zhang LW, Zhang JT. Surgical management of pediatric brainstem cavernous malformations. J Neurosurg Pediatr. 2014 May;13(5):484-502. doi: 10.3171/2014.2.PEDS13536. Epub 2014 Mar 28. PubMed PMID: 24679081.
5)
von der Brelie C, Kuczaty S, von Lehe M. Surgical management and long-term outcome of pediatric patients with different subtypes of epilepsy associated with cerebral cavernous malformations. J Neurosurg Pediatr. 2014 Jun;13(6):699-705. doi: 10.3171/2014.2.PEDS13361. Epub 2014 Apr 4. PubMed PMID: 24702617.
6)
Xia C, Zhang R, Mao Y, Zhou L. Pediatric cavernous malformation in the central nervous system: report of 66 cases. Pediatr Neurosurg. 2009;45(2):105-13. doi: 10.1159/000209284. Epub 2009 Mar 21. PubMed PMID: 19307744.
7)
Ghali MG, Srinivasan VM, Mohan AC, Jones JY, Kan PT, Lam S. Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management. Surg Neurol Int. 2016 Dec 28;7(Suppl 44):S1127-S1134. doi: 10.4103/2152-7806.196921. eCollection 2016. Review. PubMed PMID: 28194299; PubMed Central PMCID: PMC5299150.
8)
Noh JH, Cho KR, Yeon JY, Seol HJ, Shin HJ. Microsurgical treatment and outcome of pediatric supratentorial cerebral cavernous malformation. J Korean Neurosurg Soc. 2014 Sep;56(3):237-42. doi: 10.3340/jkns.2014.56.3.237. Epub 2014 Sep 30. PubMed PMID: 25368767; PubMed Central PMCID: PMC4217061.
  • pediatric_cavernous_malformation_treatment.txt
  • Last modified: 2024/06/07 02:51
  • by 127.0.0.1